An official website of the United States government
NIH Guide: Weekly Index for November 4, 2022
Weekly NIH Funding Opportunities and Notices
November 4, 2022
General Notices
-
NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Lifespan Extension in Mice
(NOT-AG-22-045)National Institute on Aging
-
Notice of Pre-Application Technical Assistance Webinar for RFA-DA-23-030, "BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed)"
(NOT-DA-22-083)National Institute on Drug AbuseNational Institute on AgingNational Institute of Neurological Disorders and Stroke
-
Notice of Extension of the Expiration Date of PAR-20-169, "National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)"
(NOT-EB-22-011)National Institute of Biomedical Imaging and BioengineeringEunice Kennedy Shriver National Institute of Child Health and Human Development
-
Request for Information (RFI) on Challenges and Opportunities Associated with Multidimensional Tumor Atlases
(NOT-CA-23-011)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice to Rescind NOT-AT-13-002 NCCAM Policy on Support of Clinical Trials in Ruth L. Kirschstein Research Awards for Predoctoral (PA-11-112), Postdoctoral Fellows (PA-11-113), Institutional, and Short-term Institutional Research (PA-11-185)
(NOT-AT-23-004)National Center for Complementary and Integrative Health
-
Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-302 NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)"
(NOT-CA-22-142)National Cancer Institute
-
Notice of Correction to Application Types Allowed in PAR-22-239, Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
(NOT-CA-23-010)National Cancer Institute
-
Notice of Need to Expire and Reissue RFA-ES-22-001 Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) to Clarify Review Criteria
(NOT-ES-23-001)National Institute of Environmental Health Sciences
-
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-146 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)"
(NOT-GM-23-009)National Institute of General Medical Sciences
-
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-147 "Maximizing Access to Research Careers (T34)"
(NOT-GM-23-013)National Institute of General Medical Sciences
-
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-025 "Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed)"
(NOT-GM-23-014)National Institute of General Medical Sciences
-
Notice of Key Date Changes to NHLBI PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)"
(NOT-HL-22-055)National Heart, Lung, and Blood Institute
-
Notice of Change to Award Budget for PHS 2022-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
(NOT-OD-23-016)Office of the Director, NIH
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed)
(NOT-AI-23-002)National Institute of Allergy and Infectious Diseases
Notices of Special Interest
-
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03)
(NOT-DA-23-012)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI) Targeting Epigenetic Regulators for Treating Addiction and Substance Use Disorders
(NOT-DA-24-004)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Supporting Data Sciences Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program
(NOT-GM-23-011)National Institute of General Medical Sciences
Funding Opportunities
-
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
(PA-23-044)Office of the Director, NIHApplication Receipt Date(s): Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
(PAR-23-033)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): March 14, 2025
-
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
(PAR-23-041)National Institute on Drug AbuseApplication Receipt Date(s): August 5, 2024
-
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)
(RFA-CA-23-018)National Cancer InstituteApplication Receipt Date(s): January 10, 2023
-
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
(RFA-CA-23-019)National Cancer InstituteApplication Receipt Date(s): January 10, 2023
-
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
(RFA-DA-24-003)National Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed)
(RFA-DA-24-004)National Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Building Research Capacity in Global Tobacco Product Regulation Program (U18) Clinical Trials Not Allowed
(RFA-FD-23-003)Food and Drug AdministrationApplication Receipt Date(s): January 16, 2023
-
Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional)
(RFA-HD-24-001)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): March 29, 2023
-
HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
(RFA-NS-22-069)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: December 13, 2024
For technical issues E-mail OER Webmaster